CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Amlitelimab

Phase 3
Sanofi (SNY)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
SNYPhase 2

Amlitelimab Phase 2 Est. Readout

Amlitelimab
Sep 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Dermatitis Atopic

View Full Landscape
Drug Information

Target Indication

Dermatitis Atopic

Clinical Trial

NCT06130566

Last updated: 12/10/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.